Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells
Authors
Keywords
-
Journal
Molecular Oncology
Volume 7, Issue 3, Pages 379-391
Publisher
Wiley
Online
2012-11-23
DOI
10.1016/j.molonc.2012.11.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Leptin Mediates Tumor-Stromal Interactions That Promote the Invasive Growth of Breast Cancer Cells
- (2012) I. Barone et al. CANCER RESEARCH
- Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs
- (2011) Xiangyi Lu et al. BIOCHEMICAL PHARMACOLOGY
- HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
- (2011) S. Modi et al. CLINICAL CANCER RESEARCH
- The multifactorial role of leptin in driving the breast cancer microenvironment
- (2011) Sebastiano Andò et al. Nature Reviews Endocrinology
- Heat shock proteins in breast cancer progression–A suitable case for treatment?
- (2010) Stuart K. Calderwood INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Heat shock factors: integrators of cell stress, development and lifespan
- (2010) Malin Åkerfelt et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element
- (2010) M. Lanzino et al. NUCLEIC ACIDS RESEARCH
- Phosphorylation of the mutant K303R estrogen receptor α at serine 305 affects aromatase inhibitor sensitivity
- (2010) I Barone et al. ONCOGENE
- Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor α and its phosphorylation at serine 305
- (2009) Cinzia Giordano et al. BREAST CANCER RESEARCH AND TREATMENT
- New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential
- (2009) Yanyan Li et al. DRUG RESISTANCE UPDATES
- Farnesoid X Receptor, through the Binding with Steroidogenic Factor 1-responsive Element, Inhibits Aromatase Expression in Tumor Leydig Cells
- (2009) Stefania Catalano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapid Estradiol/ERα Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells
- (2009) Stefania Catalano et al. MOLECULAR ENDOCRINOLOGY
- Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivoanalysis
- (2008) Elena Fiorio et al. BMC CANCER
- Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor
- (2008) N. K. Saxena et al. CANCER RESEARCH
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
- Leptin Augments Proliferation of Breast Cancer Cells via Transactivation of HER2
- (2007) Daisuke Soma et al. JOURNAL OF SURGICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started